# Nuclide record docetaxel (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/docetaxel/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "docetaxel" ;
  schema:name "Docetaxel"@en ;
  schema:description "The first chemotherapy to extend life in prostate cancer (2004), now part of triplet therapy at first metastatic diagnosis."@en ;
  schema:url <https://nuclide.cc/drugs/docetaxel/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Docetaxel> ;
  owl:sameAs <http://www.wikidata.org/entity/Q420436> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Docetaxel> ;
  nuclide:status "approved" ;
  nuclide:modality "Cytotoxic chemotherapy (taxane)" ;
  schema:alternateName "Taxotere (generic)" ;
  nuclide:approval "US 1996: Locally advanced or metastatic breast cancer after chemotherapy (Taxotere, NDA 020449)", "US 2004: Metastatic CRPC (with prednisone)" ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mhspc/>, <https://nuclide.cc/indications/prostate-mcrpc/> ;
  nuclide:trials <https://nuclide.cc/trials/chaarted/>, <https://nuclide.cc/trials/stampede/>, <https://nuclide.cc/trials/nct06520345/>, <https://nuclide.cc/trials/nct07590934/> .